JAMIE MANGOVSKI: Open Payments
NPI 1801229489 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$303 in 17 payments from 9 companies in 2025. Trend: 2023 $176 · 2024 $320 · 2025 $303
Food & beverage: $303
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $66 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Exact Sciences Corporation | 2 | $37 |
| Merck Sharp & Dohme LLC | 2 | $34 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| PFIZER INC. | 2 | $30 |
| Seqirus USA Inc | 1 | $19 |
| ABBVIE INC. | 1 | $16 |
| Novo Nordisk Inc | 1 | $15 |
Products named: MOUNJARO, FASENRA, Cologuard Collection Kit, CAPVAXIVE, PREVNAR 20, Flucelvax, SHINGRIX, TRELEGY ELLIPTA.
Industry payments across NY — which companies pay providers there.
